HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.

Abstract
Several neurodegenerative disorders, including Parkinson disease (PD), are characterized by the presence of Lewy bodies - cytoplasmic inclusions containing α-synuclein protein aggregates - in the affected neurons. A poorly understood feature of Lewy body diseases is loss of sympathetic nerves in the heart and other organs, manifesting as orthostatic hypotension (OH; also known as postural hypotension). We asked whether sympathetic denervation is associated with decreased uptake of catecholamines, such as dopamine and norepinephrine, into storage vesicles within sympathetic neurons. We used 6-[18F]-dopamine (18F-DA) to track myocardial uptake and retention of catecholamines. Concurrently, the fate of intra-neuronal 18F-DA was followed by assessment of arterial plasma levels of the 18F-DA metabolite 18F-dihydroxyphenylacetic acid (18F-DOPAC). The ratio of myocardial 18F-DA to arterial 18F-DOPAC provided an index of vesicular uptake. Tracer concentrations were measured in patients with PD with or without orthostatic hypotension (PD+OH, PD-No-OH); in patients with pure autonomic failure (PAF, a Lewy body disease without parkinsonism); in patients with multiple system atrophy (MSA, a non-Lewy body synucleinopathy); and in normal controls. Patients with PD+OH or PAF had decreased vesicular 18F-DA uptake and accelerated 18F-DA loss, compared with MSA and control subjects. PD-No-OH patients could be subtyped into one of these categories based on their initial 18F-DA uptake. We conclude that sympathetic denervation in Lewy body diseases is associated with decreased vesicular uptake of neuronal catecholamines, suggesting that vesicular monoamine transport is impaired. Vesicular uptake may constitute a novel target for diagnosis, treatment, and prevention.
AuthorsDavid S Goldstein, Courtney Holmes, Irwin J Kopin, Yehonatan Sharabi
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 121 Issue 8 Pg. 3320-30 (Aug 2011) ISSN: 1558-8238 [Electronic] United States
PMID21785221 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Catecholamines
  • Fluorine Radioisotopes
  • 3,4-Dihydroxyphenylacetic Acid
  • Desipramine
  • Dopamine
Topics
  • 3,4-Dihydroxyphenylacetic Acid (pharmacology)
  • Aged
  • Catecholamines (metabolism)
  • Cytosol (metabolism)
  • Desipramine (pharmacology)
  • Dopamine (pharmacology)
  • Female
  • Fluorine Radioisotopes (pharmacology)
  • Humans
  • Lewy Body Disease (metabolism)
  • Male
  • Middle Aged
  • Models, Biological
  • Myocardium (metabolism)
  • Neurons (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: